LeMaitre Vascular, Inc. (LMAT) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Join SI Premium – FREE
LeMaitre Vascular, Inc. (NASDAQ: LMAT) reported Q1 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $13.9 million versus the consensus estimate of $13.7 million.
LeMaitre Vascular, Inc. sees Q2 2012 revenue of $14.2 million, versus the consensus of $14.4 million.
LeMaitre Vascular, Inc. sees FY2012 revenue of $57 million, versus the consensus of $57.3 million.
For earnings history and earnings-related data on LeMaitre Vascular, Inc. (LMAT) click here.
LeMaitre Vascular, Inc. sees Q2 2012 revenue of $14.2 million, versus the consensus of $14.4 million.
LeMaitre Vascular, Inc. sees FY2012 revenue of $57 million, versus the consensus of $57.3 million.
For earnings history and earnings-related data on LeMaitre Vascular, Inc. (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- HomeTrust to acquire Blue Ridge Bankshares in $448M all-stock deal
- BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
